Successful use of an HMG-CoA reductase inhibitor as adjunctive therapy in the management of refractory bile leak complicating laparoscopic cholecystectomy.
Rabine
J
J
Division of Gastroenterology, University of Cincinnati, Ohio 45267-0595, USA.
Jones
M P
MP
D000328:Adult; D001660:Biliary Tract Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology* / Q000601:surgery; D002760:Cholangiopancreatography, Endoscopic Retrograde; D002763:Cholecystectomy / Q000009:adverse effects*; D004322:Drainage; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D010535:Laparoscopy / Q000009:adverse effects*; D008148:Lovastatin / Q000627:therapeutic use*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin